Connect with us

COVID-19

‘Incompetence’: Pentagon Doesn’t Know How Much Money It Sent To Chinese Entities For Risky Virus Research

Published

10 months ago

6 minute read

From the Daily Caller News Foundation

By NICK POPE

 

The Department of Defense (DOD) does not know how much money it directly or indirectly sent to Chinese entities to conduct research on viruses with pandemic potential, according to a new report by the DOD’s Office of Inspector General (OIG).

The OIG’s report found that DOD has supplied Chinese entities — whether directly or indirectly via subgrants — with taxpayer cash to research pathogens and the enhancement thereof, but the exact figure is unknown because of “limitations” in the DOD’s internal tracking system. Government funding for such research in China has come under scrutiny since the coronavirus pandemic, which multiple government entities believe started when an engineered virus leaked from a Chinese laboratory that was hosting U.S. government-backed gain-of-function research.

“Incompetence, absurdity, insanity; it’s hard to find a word that adequately describes this. Of all the things that DOD tracks, funds for dangerous research that could find their way to a hostile regime should be at the top of the list of those they keep close tabs on,” Michael Chamberlain, director of Protect the Public’s Trust, told the Daily Caller News Foundation regarding the OIG report’s findings. “It makes you wonder if they really know where all our nuclear warheads are. The military is one of the few areas of government in which the public still maintains a modicum of trust, but, sadly, it looks like they are working hard to squander even that.”

The OIG review of this specific issue was required by the terms of the National Defense Authorization Act (NDAA) for fiscal year 2024, which President Joe Biden signed into law in December 2023. The OIG’s investigation sought to determine just how much taxpayer cash was routed via “grants, contracts, subgrants, subcontracts, or any other type of agreement or collaboration, to Chinese research labs or to fund research or experiments in China or other foreign countries that could have reasonably resulted in the enhancement of pathogens of pandemic potential, from 2014 through 2023.”

Specifically, the OIG learned from U.S. Army officials that 12 grant awards fit the description of what it was investigating, seven of which were subgrants or subcontracts provided to entities in China or other foreign countries for research involving or related to enhanced pathogens, its report states. The OIG’s review also identified a further $9.9 million in funding that reached Chinese entities for research purposes, though that research was unrelated to pathogens.

“However, we did encounter significant challenges in searching for awards related to section 252 of the FY 2024 NDAA reporting requirement due to limitations in the DoD’s systems used to track contracts and grants,” the OIG report states. “Therefore, the full extent of DoD funds provided to Chinese research laboratories or other foreign countries for research related to enhancement of pathogens of pandemic potential is unknown.”

The issues with DOD’s grant tracking systems created “significant constraints” for OIG that “hindered [its] ability to conduct a thorough examination” of DOD’s involvement in funding this specific type of research, the report states.

The Government Accountability Office (GAO) previously conducted a similar review of DOD’s spending and Chinese entities receiving taxpayer dollars to conduct research on pathogens of pandemic potential, and its final report — published in September 2022 — also detailed similar struggles with the DoD’s grant and sub-grant tracking systems.

The Department of Energy (DOE) has concluded that the COVID-19 pandemic most likely began when the virus leaked from the Wuhan Institute of Virology in China, which was the site of gain-of-function research funded by the U.S. government via an organization called EcoHealth Alliance. Additionally, Federal Bureau of Investigation (FBI) Director Christopher Wray has acknowledged that his organization has reached a similar conclusion.

Despite this, former Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci has reiterated his position that a lab leak is the less likely scenario of the two as recently as Tuesday. The COVID-19 pandemic killed more than one million Americans, according to the Centers for Disease Control and Prevention (CDC), and millions more globally, while the American policy response to the pandemic inflicted considerable economic and social damage on the general public.

The DOD did not respond immediately to a request for comment.

Related Topics:

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

More from this author
International / 6 hours ago

Nigeria, 3 other African countries are deadliest for Christians: report

Alberta / 6 hours ago

Alberta’s future in Canada depends on Carney’s greatest fear: Trump or Climate Change

Agriculture / 6 hours ago

Liberal win puts Canada’s farmers and food supply at risk

COVID-19

Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

Published on May 1, 2025

By

From LifeSiteNews

By Nicolas Hulscher, MPH

A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna

A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.

The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:

Study Overview

  • Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
  • Intervention: Two doses of either:
    • BNT162b2 (Pfizer-BioNTech)
    • mRNA-1273 (Moderna)
  • Follow-up Duration: 12 months after second dose.
  • Comparison: Head-to-head between Pfizer vs. Moderna recipients.
  • Main Outcomes:
    • All-cause mortality
    • Cardiovascular mortality
    • COVID-19 mortality
    • Non-COVID-19 mortality

All-cause mortality

Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.

  • Pfizer Risk: 847.2 deaths per 100,000 people
  • Moderna Risk: 617.9 deaths per 100,000 people
  • Risk Difference:
    ➔ +229.2 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.37 (i.e., 37% higher mortality risk with Pfizer)
  • Odds Ratio (Adjusted):
    ➔ 1.384 (95% CI: 1.331–1.439)

Cardiovascular mortality

Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.

  • Pfizer Risk: 248.7 deaths per 100,000 people
  • Moderna Risk: 162.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +86.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.53 (i.e., 53% higher cardiovascular mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.540 (95% CI: 1.431–1.657)

COVID-19 mortality

Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.

  • Pfizer Risk: 55.5 deaths per 100,000 people
  • Moderna Risk: 29.5 deaths per 100,000 people
  • Risk Difference:
    ➔ +26.0 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.88 (i.e., 88% higher COVID-19 mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.882 (95% CI: 1.596–2.220)

Non-COVID-19 mortality

Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.

  • Pfizer Risk: 791.6 deaths per 100,000 people
  • Moderna Risk: 588.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +203.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.35 (i.e., 35% higher non-COVID mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.356 (95% CI: 1.303–1.412)

Biological explanations

The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:

The paper hypothesizes differences between Pfizer and Moderna may be due to:

  • Different lipid nanoparticle compositions
  • Differences in manufacturing, biodistribution, or storage conditions

Final conclusion

Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.

Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.

As the authors conclude:

These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.

Reprinted with permission from Focal Points.

Continue Reading

COVID-19

Canada’s health department warns COVID vaccine injury payouts to exceed $75 million budget

Published on April 30, 2025

By

Fr0m LifeSiteNews

By Clare Marie Merkowsky

A Department of Health memo warns that Canada’s Vaccine Injury Support Program will exceed its $75 million budget due to high demand, with $16 million already paid out.

COVID vaccine injury payments are expected to go over budget, according to a Canadian Department of Health memo.

According to information published April 28 by Blacklock’s Reporter, the Department of Health will exceed their projected payouts for COVID vaccine injuries, despite already spending $16 million on compensating those harmed by the once-mandated experimental shots.

“A total $75 million in funding has been earmarked for the first five years of the program and $9 million on an ongoing basis,” the December memo read. “However the overall cost of the program is dependent on the volume of claims and compensation awarded over time, and that the demand remains at very high levels.”

“The purpose of this funding is to ensure people in Canada who experience a serious and permanent injury as a result of receiving a Health Canada authorized vaccine administered in Canada on or after December 8, 2020 have access to a fair and timely financial support mechanism,” it continued.

Canada’s Vaccine Injury Support Program (VISP) was launched in December 2020 after the Canadian government gave vaccine makers a shield from liability regarding COVID-19 jab-related injuries.

While Parliament originally budgeted $75 million, thousands of Canadians have filed claims after received the so-called “safe and effective” COVID shots. Of the 3,060 claims received to date, only 219 had been approved so far, with payouts totaling over $16 million.

Since the start of the COVID crisis, official data shows that the virus has been listed as the cause of death for less than 20 kids in Canada under age 15. This is out of six million children in the age group.

The COVID jabs approved in Canada have also been associated with severe side effects such as blood clots, rashes, miscarriages, and even heart attacks in young, healthy men.

Additionally, a recent study done by researchers with Canada-based Correlation Research in the Public Interest showed that 17 countries have found a “definite causal link” between peaks in all-cause mortality and the fast rollouts of the COVID shots as well as boosters.

Interestingly, while the Department of Health has spent $16 million on injury payouts, the Liberal government spent $54 million COVID propaganda promoting the vaccine to young Canadians.

The Public Health Agency of Canada especially targeted young Canadians ages 18-24 because they “may play down the seriousness of the situation.”

The campaign took place despite the fact that the Liberal government knew about COVID vaccine injuries, according to a secret memo.

Continue Reading

Trending

X